Plasma acylcarnitines could predict prognosis and evaluate treatment of IgA nephropathy
Abstract Background Effective evaluation or prediction of therapy response could be helpful for treatment of chronic kidney disease (CKD), which may rely on accurate biomarkers. Acylcarnitines are involved with lipid metabolism and mitochondrial function. The relation of acylcarnitines with treatmen...
Main Authors: | Fang-Ying Xia, Li Zhu, Chao Xu, Qing-Qing Wu, Wan-Jia Chen, Rong Zeng, Yue-Yi Deng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-01-01
|
Series: | Nutrition & Metabolism |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12986-018-0328-1 |
Similar Items
-
Predictors of prognosis in IgA nephropathy
by: Yasuhiko Tomino
Published: (2012-10-01) -
IgA Vasculitis and IgA Nephropathy: Same Disease?
by: Evangeline Pillebout
Published: (2021-05-01) -
The Association between Serum Hemoglobin and Renal Prognosis of IgA Nephropathy
by: Tae Ryom Oh, et al.
Published: (2021-01-01) -
An Update on the Current State of Management and Clinical Trials for IgA Nephropathy
by: Chee Kay Cheung, et al.
Published: (2021-06-01) -
History of IgA Nephropathy Mouse Models
by: Batoul Wehbi, et al.
Published: (2021-07-01)